Epitope mapping by epitope excision, hydrogen/deuterium exchange, and peptide-panning techniques combined with in silico analysis.

The fine characterization of protective B cell epitopes plays a pivotal role in the development of novel vaccines. The development of epitope-based vaccines, in fact, cannot be possible without a clear definition of the antigenic regions involved in the binding between the protective antibody (Ab) and its molecular target. To achieve this result, different epitope-mapping approaches have been widely described (Clementi et al. Drug Discov Today 18(9-10):464-471, 2013). Nowadays, the best way to characterize an Ab bound region is still the resolution of Ab-antigen (Ag) co-crystal structure. Unfortunately, the crystallization approaches are not always feasible. However, different experimental strategies aimed to predict Ab-Ag interaction and followed by in silico analysis of the results may be good surrogate approaches to achieve this result. Here, we review few experimental techniques followed by the use of "basic" informatics tools for the analysis of the results.

[1]  Roded Sharan,et al.  Pepitope: epitope mapping from affinity-selected peptides , 2007, Bioinformatics.

[2]  Nicola Clementi,et al.  Characterization of epitopes recognized by monoclonal antibodies: experimental approaches supported by freely accessible bioinformatic tools. , 2013, Drug discovery today.

[3]  Helge-Friedrich Tippmann,et al.  Software review: Analysis for free: Comparing programs for sequence analysis , 2004, Briefings Bioinform..

[4]  Renate Kunert,et al.  Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41. , 2005, Immunity.

[5]  Nicola Clementi,et al.  Influenza B-cells Protective Epitope Characterization: A Passkey for the Rational Design of New Broad-Range Anti-Influenza Vaccines , 2012, Viruses.

[6]  J. Ball,et al.  Hepatitis C Virus (HCV) Infection May Elicit Neutralizing Antibodies Targeting Epitopes Conserved in All Viral Genotypes , 2009, PloS one.

[7]  M. Clementi,et al.  Cloning and molecular characterization of a human recombinant IgG Fab binding to the Tat protein of human immunodeficiency virus type 1 (HIV-1) derived from the repertoire of a seronegative patient. , 2006, Molecular immunology.

[8]  A. Osman,et al.  Epitope mapping by screening of phage display libraries of a monoclonal antibody directed against the receptor binding domain of human α2‐macroglobulin , 1997, FEBS letters.

[9]  J. Whisstock,et al.  Prediction of the Immunodominant Epitope of the Pyruvate Dehydrogenase Complex E2 in Primary Biliary Cirrhosis Using Phage Display , 2000, The Journal of Immunology.

[10]  L. Gubareva,et al.  A Human Monoclonal Antibody with Neutralizing Activity against Highly Divergent Influenza Subtypes , 2011, PloS one.

[11]  S. Tuske,et al.  Epitope mapping by amide hydrogen/deuterium exchange coupled with immobilization of antibody, on-line proteolysis, liquid chromatography and mass spectrometry. , 2009, Rapid communications in mass spectrometry : RCM.

[12]  Rodrigo Lopez,et al.  Clustal W and Clustal X version 2.0 , 2007, Bioinform..

[13]  C. Hager-Braun,et al.  Determination of protein-derived epitopes by mass spectrometry , 2005, Expert review of proteomics.

[14]  Oleg V. Tsodikov,et al.  Novel computer program for fast exact calculation of accessible and molecular surface areas and average surface curvature , 2002, J. Comput. Chem..

[15]  J. Wijdenes,et al.  Identification and location on syndecan‐1 core protein of the epitopes of B‐B2 and B‐B4 monoclonal antibodies , 1998, FEBS letters.

[16]  Minoru Kanehisa,et al.  MIMOX: a web tool for phage display based epitope mapping , 2006, BMC Bioinformatics.

[17]  L. Gubareva,et al.  A Non-VH1-69 Heterosubtypic Neutralizing Human Monoclonal Antibody Protects Mice against H1N1 and H5N1 Viruses , 2012, PloS one.